Mirador Capital Partners LP trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 29.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 8,263 shares of the company’s stock after selling 3,505 shares during the quarter. Mirador Capital Partners LP’s holdings in Astera Labs were worth $2,941,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of ALAB. Greenleaf Trust raised its stake in shares of Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after acquiring an additional 36 shares during the period. Parkside Financial Bank & Trust boosted its position in Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after purchasing an additional 41 shares during the period. Glenmede Trust Co. NA boosted its position in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the period. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the 2nd quarter valued at $25,000. Finally, Integrated Wealth Concepts LLC increased its holdings in Astera Labs by 0.7% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after purchasing an additional 52 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on ALAB. Needham & Company LLC boosted their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Roth Capital reissued a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Friday. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $348.33.
Astera Labs Price Performance
Shares of Astera Labs stock opened at $342.21 on Friday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market capitalization of $59.37 billion, a PE ratio of 169.41 and a beta of 3.68. The business has a 50-day moving average of $317.44 and a 200-day moving average of $290.39.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 over the last 90 days. 10.40% of the stock is currently owned by corporate insiders.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
- Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
- Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
- Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
- Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation
About Astera Labs
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.
Featured Stories
- Five stocks we like better than Astera Labs
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
